Clinical cases of the drug-resistant fungus Candida auris rose over 50% from 2022 to 2023, with 4,514 cases reported across 36 US states and Washington, D.C., according to data reported to the CDC. This is a significant increase from 2,928 cases in 2022. C. auris poses a significant public health threat due to its resistance to multiple antifungal treatments and ability to rapidly spread in healthcare settings.
Australian Clinical Labs says limited data taken in SunDoctors cyberattack – whbl.com
Australian Clinical Labs says limited data taken in SunDoctors cyberattack whbl.com
